Skip to content

The clinical application of suPARD2D3 in the diagnosis of diabetic nephropathy based on time-resolved fluorescence immunoassay

The clinical application of suPARD2D3 in the diagnosis of diabetic nephropathy based on time-resolved fluorescence immunoassay

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400094390
Enrollment
Unknown
Registered
2024-12-22
Start date
2024-12-31
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic nephropathy

Interventions

Gold Standard:Those with a definite history of diabetes, having a causal relationship with changes in urinary protein and renal function, and excluding other primary and secondary glomerular diseases
Index test:Diagnostic test method: Time-resolved fluorescence immunoassay

Sponsors

The First Affiliated Hospital of Army Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1.There is no gender limitation, and the age range is from 18 to 70 years old. 2.Patients who are hospitalized in the nephrology department of our hospital and have undergone renal biopsy, with a definite pathological diagnosis of kidney diseases. 3.Serum and urine samples have been reserved in the biobank of our hospital.

Exclusion criteria

Exclusion criteria: 1.Those with active infections. 2.Those with any more complicated medical problems that may interfere with the levels of suPAR D2D3, such as malignant tumors, connective tissue diseases, autoimmune diseases, etc.

Design outcomes

Primary

MeasureTime frame
suPAR D2D3;Accuracy;Sensitivity;Specificity;

Secondary

MeasureTime frame
Positive predicative value;Negative predictive value;

Countries

China

Contacts

Public ContactZhao Hongwen

The First Affiliated Hospital of Army Medical University

zhaohw212@126.com+86 13983360655

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026